To determine whether insulin regulates vascular smooth muscle Na § , K § activity and if impaired insulin stimulation of vascular smooth muscle Na +, K +-ATPase activity could be a cause of increased vascular reactivity to norepinephrine and angiotensin II in diabetic states, the effects of insulin on Na +, K +-ATPase activity were examined in normal rabbit aortic intima-media incubated with normal plasma glucose and rnyo-inositol levels for 30 min. Insulin at 100 gU/ml (600 pmol/1) had no effect on Na+, K +-ATPase activity. At 250 ~tU/ml it caused a 4.2 + 0.8 % increase, and at 500 gU/ml insulin caused a 17.7 + 1.4 % increase in Na +, K + -ATPase activity that was completely inhibited by amiloride (1 mmol/1). Human insulin-like growth factor I (600 pmol/1) caused an 18.0 _+ 1.0 % increase in Na', K +-ATPase activity that was inhibited by amiloride. Insulin does not regulate (stimulate) aortic vascular smooth muscle Na § K+-ATPase activity. Supraphysiological insulin concentrations, probably acting through an insulin-like growth factor I receptor, stimulate Na+/H + exchange in aortic vascular smooth muscle and cause small secondary increases in Na T, K § activity. In aortic intima-media incubated with normal plasma glucose and myo-inositol levels, endogenously released adenosine stimulates and maintains a component of resting Na +, K +-ATPase activity and stimulates acute increases in activity when norepinephrine (1 gmol/1) or angiotensin II (100 nmol/1) is added. These adenosine-stimulated components of Na +, K +-ATPase activity are selectively inhibited when the medium glucose is raised to 30 retool/1 during a 30-rain equilibration and 30-rain incubation. Insulin (100 gU/ml) added during the incubation had no effect on the alterations in Na +, K § activity induced by glucose at an elevated plasma level. Impaired insulin stimulation of vascular smooth muscle Na +, K'-ATPase activity is not a possible cause for alterations in vascular reactivity in diabetes.
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Some factor or factors present in all diabetic states (e. g. hyperglycaemia, insulin deficiency or resistance) causes increased reactivity to norepinephrine and angiotensin II in specific arteries and arterioles. Thus the vasopressor responses to i.v. norepinephrine and angiotensin II are increased in diverse diabetic states, even when vascular complications, hyperinsulinaemia, or hypertension are absent. Increased contractile responses to these vasoconstrictors have been demonstrated in specific arteries and arterioles from rats and rabbits with diabetes induced by a beta-cell toxin [1] [2] [3] [4] [5] [6] . Further, insulin treatment of streptozotocin diabetic rats is known to correct the increased reactivity of their aortae and mesenteric arteries to norepinephrine [7] . Decreased vascular smooth muscle (VSM) Na + , K+-ATPase activity is a cause for increased contractile responses to norepinephrine and angiotensin II and a postulated cause for essential hypertension [8, 9] . Whether insulin regulates (stimulates) Na +, K § ATPase activity in VSM, as it does in adipocytes and skeletal muscle, is unknown. We examined this question in normal rabbit aortic intima-media (AIM), a commonly used system for studies of VSM, to assess whether impaired insulin stimulation of VSM Na § K+-ATPase activity is a possible cause for decreased VSM Na § K +-ATPase activity and resulting alterations in vascular reactivity in diabetic states.
The mechanism by which hyperglycaemia decreases Na +, K +-ATPase activity in specific tissues and blood vessels has effects which are preventable in diabetic animals both by aldose reductase inhibitors and by raising the normal plasma myo-inositol (MI) levels approximately seven-fold [10] [11] [12] . This mechanism can be activated in vitro in normal rabbit AIM, and it was recently found to decrease VSM Na +, K+-ATPase activity by inhibiting a novel adenosine-Na § K+-ATPase regulatory system, which plays a role in the modulation of the responses to norepinephrine and angiotensin II in AIM [13] [14] [15] . Adenosine is an autocoid and one of the endothelium-released vasodilators [16] [17] [18] . Stimulation of increased electrogenic Na +, K +-ATPase activity in VSM is one of the mechanisms by which endothelium-released vasodilators modulate vasoconstriction [18, 19] . In AIM incubated with normal plasma glucose and MI levels, endogenously released adenosine stimulates and maintains a distinct component of resting Na + , K +-ATPase activity and also stimulates acute increases in Na +, K+-ATPase activity when AIM is exposed to norepinephrine or angiotensin II to modulate the response [14, 15] . These normal adenosine-stimulated components of Na +, K § activity are selectively inhibited within 60 rain when the medium glucose is raised from a normal to a threshold elevated plasma level (10 mmol/1) or to 30 mmol/1 [13] [14] [15] . Exposing AIM to an elevated glucose level induces increased polyol pathway activity that impairs MI transport at a normal plasma MI level; this inhibits the adenosine effect on Na +, K + -ATPase activity, because this effect is mediated through a receptor that stimulates phosphatidylinositol turnover (hydrolysis) in a discrete pool, which is maintained by a fraction of phosphatidylinositol synthesis that selectively requires MI transport to prevent its rapid inhibition [13, 14] . We also examined the effects of insulin on the alterations in Na +, K +-ATPase activity caused by exposing AIM to glucose in an elevated plasma level.
Materials and methods
Male, white New Zealand rabbits (2.0-2.5 kg) were fasted overnight, sedated with diazepam (2 mg/kg i.m.), and 90 rain later anaesthetized with sodium pentobarbital (30 mg/kg i. v.) and decapitated. The descending aorta was rapidly excised and used to prepare four tubular segments of AIM, each weighing approximately 30 mg; the method employed provides AIM that is free of adventitia and retains an intact endothelium with a normal transmission and scanning electron microscopic appearance [20, 21] . All of the media to which the aorta and AIM were exposed contained 9 % clinical grade dextran (average Mr 70,000) to provide the oncotic pressure that is required to preserve an intact endothelium with a normal ultrastructural appearance in AIM and the normal pattern of energy metabolism in its constituent VSM cells [20, 21] . The aorta was dissected in KrebsHenseleit bicarbonate buffer [22] (which has normal plasma concentrations of Na + and K +), pH 7.4 at 37 ~ that contained normal rabbit plasma levels of glucose (5 mmol/1) and MI (70 gmol/1) and was continuously bubbled with 5 % COJ95 % 02.
For each experiment the four AIM segments from a single aorta were used to provide two paired samples, each comprised of two individual AIM segments. The Na +, K +-ATPase-mediated 86Rb § § uptake in the paired samples was compared during incubations in similar medium with insulin, insulin-like growth factor I, norepinephrine, or angiotensin II added to one of the paired samples. The method for the determination of Na +, K+-ATPase-mediated 86Rb+/K + uptake in AIM has been previously reported in detail [13] . Briefly, the individual freshly prepared AIM segments were equilibrated for 30 min in 3.0 ml of Krebs-Henseleit bicarbonate buffer, pH 7.4 at 37 ~ containing 9 % dextran, 70 bunol/l MI, and glucose in a specified concentration, in a 10 ml Erlenmeyer flask continuously gassed with 5 % CO2/air, in a metabolic shaker set at 88 cycles per rain. The individual AIM segments were then transferred to 3.0 ml of fresh medium of the same composition to which a tracer quantity of [3H]sucrose had been added; ouabain (0.2 mmol/1) was added to one of two AIM segments in each paired sample, and the tissue was incubated as described for the equilibration. After the initial 10 min of the incubation a tracer quantity of [86Rb + ]RbC1 was added to each flask and the incubation continued for an additional 20 min. At the end of the incubation the individual AIM segments were rapidly removed, drained on filter paper, weighed, and transferred into 2 ml of Protosol in a glass liquid scintillation vial and digested for 16 h. The tissue digest was then decolorized with H202, Econofluor 2 was added to the vial, and the sample counted for 86Rb + and 3H in a liquid scintillation spectrometer with an external standard. A sample of the Table 2 . Effects ofinsulin (100 ~tU/ml), norepinephrine, and angiotensin II on Na+, K +-ATPase activity in aortic infima-media incubated with 30 retool/1 or 5 mmolfl glucose and a normal plasma myo-inositol level 
Statistical analysis
The mean A + SEM between the paired samples incubated in the absence and presence of the agonist tested in each group of paired experiments was analysed for significance by a Student's paired t-test analysis.
Results
Paired AIM samples taken from normal rabbits after an overnight fast were equilibrated and then incubated for 30 min in medium containing normal rabbit plasma concentrations of glucose (5 retool/l) and MI (70 gmol/1) with insulin added to one sample, and the Na +, K +-ATPasemediated S6Rb +/K + uptakes in the paired samples compared during the final 20 rain of the incubation. Insulin at a concentration of 100 gU/ml (600 pmol/1) had no effect on Na-, K + -ATPase activity (Table 1 ). Insulin at a concentration of 250 gU/ml caused a very small but significant increase in Na +, K+-ATPase activity (Table 1) ; the mean percentage increase + SEM in the paired sampies was only 4.2 + 0.8%. Insulin at 500 gU/ml caused a greater, but still relatively small, increase in Na +, K +-ATPase activity (Table 1) ; the mean percentage increase + SEM was 17.7 _+ 1.4%. When amiloride (1 mmol/1), an inhibitor of the Na +, H + exchanger [23] , was added to the incubation medium, the addition of 500 gU/ml insulin had no significant effect on Na § K +-ATPase activity (Table 1) .
Human insulin-like growth factor I (600 pmol/1) caused a significant increase in Na +, K+-ATPase activity in AIM incubated with normal plasma levels of glucose and MI for 30 min (Table 1) : the mean percentage increase + SEM was 18.0 +_ 1.0 %. The magnitude of the increase in Na +, K+-ATPase-mediated S6Rb+/K + uptake evoked by 600 pmol/1 insulin-like growth factor I was similar to that evoked by 3000 pmol/1 (500 gU/ml) insulin (Table 1) . When amiloride (1 mmol/1) was added to the incubation medium, insulin-like growth factor I (600 pmol/1) had no effect on Na + , K +-ATPase activity (Table 1) .
Previous studies in paired AIM samples demonstrated that in medium containing MI at a normal plasma level (70 gmol/1) raising the medium glucose from 5 to 30 mmol/1 during a 30-min equilibration and a 30-rain incubation causes a significantly reduced rate of Na +, K +-ATPase-mediated 86Rb +/K" uptake during the final 20 min of the incubation [13, 14] . In paired AIM samples that were both equilibrated and incubated in medium containing 30 mmol/1 glucose and 70 gmol/1 MI, the addition of insulin (100 gU/ml) to one sample during the 30-rain incubation had no effect on the reduced resting rate of Na +, K § activity (Table 2) . Paired AIM samples were equilibrated and then incubated for 30 rain in medium containing 5 mmol/1 glucose and 70 gmol/1 MI with 100 gU/ml insulin added to both samples; under these conditions the addition of norepinephrine (1 gmol/1) or of angiotensin II (100 nmot/1) to one paired sample during the final 20 min of the incubation evoked a significant increase in Na +, K +-ATPase activity (Table 2) . When these experiments were repeated but with the medium glucose raised from 5 to 30 mmol/1, the addition of norepinephrine (1 btmol/1) or of angiotensin II (100 nmol/1) evoked no significant change in Na +, K § ATPase activity (Table 2) .
Discussion
In most mammalian cells Na +, K+-ATPase activity is acutely regulated primarily or in part by the intracellular [Na § ] and an increase in the normal intracellular [Na + ] automatically increases Na +, K+-ATPase activity [24] . This accounts for the fact that in specific cell types insulin stimulation of a biological process that causes increased Na § influx can evoke a secondary increase in Na § K +-ATPase activity [25] ; such an insulin effect is distinct from insulin regulation of Na § , K +-ATPase activity per se and its demonstration does not identify a cell type in which insulin deficiency or resistance is a potential cause for a derangement in the regulation of Na § , K +-ATPase activity (or of intracellular [NAP]). Insulin regulates (stimulates) Na +, K +-ATPase activity only in specific cell types which do not include all of the cell types in which insulin has acute metabolic effects. Thus insulin regulates Na + , K +-ATPase activity in adipocytes [26, 27] and skeletal muscle [28] but not in hepatocytes [25] . Insulin stimulates increased Na +, K § 86Rb +/K § uptake in rat adipocytes and soleus muscle that is readily demonstrable during a 20-25 rain exposure to the hormone and does not result from an increase in intracellular [Na +] or from an increase in Na +, K+-ATPase molecules in the plasma membrane [26] [27] [28] . In adipocytes insulin has been found to stimulate Na +, K +-ATPase activity by decreasing the Km's for intracellular Na + of the alpha2 and alpha1 Na +, K +-ATPase isoforms in the cell and by increasing the Vma• of the alpha2 isoform, whose activity is most markedly affected by insulin [26] . Insulin causes half-maximal stimulation of Na +, K +-ATPase-mediated S6Rb +/K + uptake in adipocytes at 33 ~uU/ml [27] .
We examined the effects of insulin on Na +, K +-ATPase-mediated 86Rb+/K+ uptake in normal rabbit AIM, one of the most extensively used systems for studies of hormonal and neurotransmitter affects in VSM [29] . VSM cells comprise most of the cell mass in AIM, and these VSM retain their normal histological relationship(s) with the endothelium, whose injury or removal rapidly alters the normal pattern of energy metabolism in the VSM cells [20, 21] and also alters their responses to some hormones and neurotransmitters [18] . The AIM preparation employed in this study retains an intact, ultrastructurally normal endothelium and its normal pattern of energy metabolism [20, 21] . When AIM from normal, overnight fasted rabbits is incubated with normal rabbit plasma levels of glucose (5 retool/l) and MI (70 gmol/1) in Krebs-Henseleit bicarbonate buffer containing 9% dextran, the resting AIM maintains a stable rate of Na +, K*-ATPase-medi -215 ated S6Rb+/K* uptake that is comprised of two distinct components [13, 14] . Under these conditions, exposing AIM to insulin at a high physiological plasma level, 100 gU/ml, for 30 min had no effect on its Na § , K+-ATPase activity. At 250 btU/ml insulin caused a very small increase in Na § K +-ATPase activity (4.2 _+ 0.8 %). At 500 gU/ml insulin caused a larger, but still small, increase in Na +, K § activity (17.7 + 1.4 %) that was completely inhibited by amiloride (1 mmol/1), an inhibitor of the Na+/H § exchange system [23] . It thus appears that insulin does not regulate (stimulate) VSM Na +, K *-ATPase activity in AIM, but that supraphysiological insulin concentrations stimulate Na+/H + exchange in VSM and cause small secondary increases in Na § K+-ATPase activity.
An insulin effect in an isolated tissue that is demonstrable only at supraphysiological concentrations may reflect an effect that results from insulin binding to an insulin-like growth factor I receptor [30] . Furthermore, many growth factors have been found to stimulate Na+/H § exchange in their target cells [31] . Human, insulin-like growth factor I (600 pmol/1) was found to cause an increase in Na +, K +-ATPase activity in AIM incubated with normal plasma levels of glucose and MI, which was inhibited by amiloride. The effect of insulin-like growth factor I on Na +, K +-ATPase activity in AIM was demonstrable at a molar concentration at which insulin has no effect on Na +, K+-ATPase activity, and 600 pmol/1 insulin-like growth factor I caused an increase in Na § K § activity similar to that caused by 3000 pmol/1 (500 btU/ml) insulin. This suggests that supraphysiological insulin concentrations probably stimulate Na+/H + exchange and cause secondary increases in Na § K+-ATPase activity in VSM by cross-reacting with an insulin-like growth factor I receptor.
As noted previously, a mechanism has been identified in rabbit AIM by which hyperglycaemia could decrease Na § , K § activity in resting VSM and also impair adenosine-mediated modulation of VSM contractile responses to norepinephrine and angiotensin II in specific vessels [13] [14] [15] . In normal AIM exposure to glucose at an elevated plasma level for a short period causes derangements in Na § , K § -ATPase activity by inducing increased polyol pathway activity that impairs MI transport at a normal plasma MI level and thereby inhibits the effector arm of a novel adenosine-Na *, K +-ATPase regulatory system [13, 14] . Insulin does not have acute effects on the major, commonly studied parameters of glucose metabolism in rabbit AIM that is free of adventitial adipocytes [32] [33] [34] . However, the possibility remained that insulin at physiological plasma levels might modify the effects of an elevated glucose level on Na +, K § activity in AIM if insulin had some presently unknown effect on polyol pathway activity or MI transport in AIM. In AIM provided with medium MI at a normal plasma MI level, raising the medium glucose from 5 to 10 or 30 mmol/1 during a 30-min equilibration and 30-min incubation selectively inhibits a distinct adenosine-stimulated component of resting Na +, K+-ATPase activity and the adenosinestimulated increases in Na +, K +-ATPase activity that are normally evoked when AIM is exposed to norepinephrine (1 gmol/1) or angiotensin II (100 nmol/1) in a concentration known to cause contraction in rabbit aorta. These alterations in Na +, K +-ATPase activity are prevented if an aldose reductase inhibitor is added or if the medium MI is raised seven-fold [13] [14] [15] . In AIM equilibrated and incubated in medium containing 30 mmol/1 glucose and MI at a normal plasma level, adding insulin (100 gU/ml) during the 30-min incubation had no effect on the reduced resting rate of Na +, K § activity and did not modify the complete inhibition of the increases in Na § K+-ATPase activity that are normally evoked when AIM is stimulated by norepinephrine (1 gmol/1) or angiotensin II (100 nmol/1). It thus appears that the presence (or absence) of insulin at a high physiological plasma level does not modify the derangements in VSM Na +, K § activity in AIM that result from exposure to glucose in an elevated plasma level.
Our observations provide no support for the frequent speculation that insulin deficiency or resistance in VSM would impair a normal insulin stimulation of VSM Na +, K +-ATPase activity and is a potential cause for decreased VSM Na +, K +-ATPase activity and resulting alterations in vascular reactivity in diabetic states [35] . Rather, our observations suggest that hyperglycaemia is probably the factor that induces increased reactivity to norepinephrine and angiotensin II in specific arteries and arterioles in diabetic states.
Insulin resistance per se in VSM has also been postulated to be a possible cause for hypertension and for the reported associations between various insulin-resistant states and hypertension [35] . This hypothesis is based on the premise that insulin resistance in VSM could cause the loss of normal insulin stimulatory effects on glucose utilization for energy provision or on Na +, K +-ATPase activity and thereby cause derangements in ionic regulation in VSM that increase the vasoconstrictive responses to norepinephrine and angiotensin II [35] . This hypothesis is untenable, because a body of evidence indicates that insulin does not regulate glucose metabolism in VSM [32] [33] [34] and because the observations in this report indicate that insulin does not regulate Na +, K +-ATPase activity in VSM.
